Triumvira Immunologics Inc.
Biotechnology company · Austin, Texas, United States
Triumvira Immunologics Inc. is a biotechnology company headquartered in Austin, Texas, United States. It has reported private securities offerings to the US SEC, most recently $60 million sold in a notice filed in 2022.
Profile compiled from public records. Is this your company? Request a correction or update
Triumvira Immunologics at a glance
Typebiotechnology company
HeadquartersAustin, Texas, United States
SEC CIK1861332
What does Triumvira Immunologics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $59.7 million sold (2022).
Frequently asked questions about Triumvira Immunologics
Where is Triumvira Immunologics headquartered?
Triumvira Immunologics Inc. is headquartered in Austin, Texas, United States.
What does Triumvira Immunologics do?
Triumvira Immunologics Inc. is a biotechnology company.
Similar companies
- Alleviant Medical, Inc.Austin, Texas, United States
- Maxwell Biosciences, Inc.Austin, Texas, United States
- 4e Therapeutics, Inc.Austin, Texas, United States
- Pelican Therapeutics, Inc.Austin, Texas, United States
- Windmill Cardiovascular Systems IncAustin, Texas, United States
- IntraBio Inc.Austin, Texas, United States
- Direct Biologics, LLCAustin, Texas, United States
- Mati Therapeutics Inc.Austin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences